NN6 Share Price Performance
€1.58
-0.20 (-11.27%)
Price €1.58
Share Price€1.58
NN6 Community Narratives
There are no narratives available yet.
Recent NN6 News & Updates
No updates
NanoRepro AG Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.16
- Gross Margin
- 61.38%
- Net Profit Margin
- -45.36%
- Debt/Equity Ratio
- 0%
NanoRepro AG Competitors
About NN6
- Founded
- 2006
- Employees
- 23
- CEO
- WebsiteView website
NanoRepro AG develops, manufactures, and distributes rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. It provides products in the areas of family planning and disease detection, as well as food intolerances, allergies, and infectious diseases. The company offers rapid diagnostic tests, such as family planning, and preventive healthcare line products; tests for hospitals and medical practices to detect aids, Troponin I, D-dimer, streptococci antigen, influenza type A and B antigens, and microalbumin; and immunochromatographic lateral flow tests for the diagnostic detection of biomarkers, as well as SARS-CoV-2 antibody test and corona antigen rapid test. It also provides food supplements for men and women, including Alphabiol Beauty Elixier for the skin shine based on combination of micronutrients; Alphabiol Fertility for men; Alphabiol Curcumin Elixier mit Curcumin + Vitamin D, an essential nutrient for Vitamin D through online shops and pharmacies. The company was founded in 2006 and is headquartered in Marburg, Germany.
German Market Performance
- 7 Days: 1.2%
- 3 Months: -2.8%
- 1 Year: 23.7%
- Year to Date: 6.0%
The market has climbed 1.2% in the last 7 days, lead by the Communication Services sector with a gain of 13%. In contrast, the Consumer Discretionary sector is lagging, dropping 4.7%. As for the past 12 months, the market is up 24%. Earnings are forecast to grow by 17% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading